Huoxin Pill (活心丸) Attenuates Cardiac Fibrosis by Suppressing TGF-β1/Smad2/3 Pathway in Isoproterenol-Induced Heart Failure Rats

Mei-zhong PENG; Mei-ling YANG; A-ling SHEN; Xue-ling ZHOU; Yan LU; Qi LI; Zhi-qing SHEN; Bin HUANG; Jun PENG; Jian-feng CHU

doi:10.1007/s11655-020-2862-8

Your Location：

Home >

Browse articles >

Huoxin Pill (活心丸) Attenuates Cardiac Fibrosis by Suppressing TGF-β1/Smad2/3 Pathway in Isoproterenol-Induced Heart Failure Rats

Original Article | Updated：2021-09-01

- Huoxin Pill (活心丸) Attenuates Cardiac Fibrosis by Suppressing TGF-β1/Smad2/3 Pathway in Isoproterenol-Induced Heart Failure Rats
- Chinese Journal of Integrative Medicine Vol. 27, Issue 6, Pages: 424-431(2021)
- Affiliations：
  
  1.Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou (350122), China
  2.Chen Keji Academic Thought Inheritance Studio, Fujian University of Traditional Chinese Medicine, Fuzhou (350122), China
  3.Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou (350122), China
  4.The Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou (350122), China
  5.Department of Research and Development, Youcare Pharmaceutical Group Co., Ltd., Beijing (100176), China
- Author bio：
  
  Dr. CHU Jian-feng, E-mail: jianfengchu@126.com
- Funds：
- DOI：10.1007/s11655-020-2862-8
  CLC：
- Published：01 June 2021，
  
  Published Online：22 December 2020，
  
  Accepted：16 June 2020
Scan for full text
Mei-zhong PENG, Mei-ling YANG, A-ling SHEN, et al. Huoxin Pill (活心丸) Attenuates Cardiac Fibrosis by Suppressing TGF-β1/Smad2/3 Pathway in Isoproterenol-Induced Heart Failure Rats. [J]. Chinese Journal of Integrative Medicine 27(6):424-431(2021)
DOI：

Mei-zhong PENG, Mei-ling YANG, A-ling SHEN, et al. Huoxin Pill (活心丸) Attenuates Cardiac Fibrosis by Suppressing TGF-β1/Smad2/3 Pathway in Isoproterenol-Induced Heart Failure Rats. [J]. Chinese Journal of Integrative Medicine 27(6):424-431(2021) DOI： 10.1007/s11655-020-2862-8.

摘要

Abstract

Objective:

To evaluate the effects of Huoxin Pill (活心丸

HXP) on cardiac fibrosis and heart failure (HF) in isoproterenol (ISO)-induced HF rats.

Methods:

Thirty Wistar rats were randomly divided into 5 groups including control

isosorbide mononitrate (ISMN)

HXP low (HXP-L)

and HXP high (HXP-H) groups (

=6 for each group) according to the complete randomization method. Rats were pretreated with ISMN (5 mg/kg daily)

low concentration of HXP (10 mg/kg daily) or high concentration of HXP (30 mg/kg daily) or equal volume of saline by intragastric administration for 1 week

followed by intraperitoneal injection of ISO (10 mg/kg

14 days)

and continually intragastric administrated with above medicines or saline for additional 6 weeks. The effects of HXP treatment on the cardiac function

heart weight index (HWI)

pathological changes

and collagen content were further assessed. Moreover

the role of HXP on activation of transforming growth factor-β1 (TGF-β1)/Smads pathway was further explored using immunohistochemistry (IHC) and Westernblot assay.

Results:

HXP treatment significantly alleviated the decrease of ejection fraction (EF) and fractional shortening (FS)

while decreased the elevation of left ventricular end-systolic volume (LVESV) in ISO-induced HF rats (

0.05). Moreover

HXP treatment obviously attenuated the increase of HWI and serum level of creatine kinase MB (CK-MB

0.05)

as well as pathological changes in ISO-induced HF rats. Further determination indicated that HXP treatment alleviated the elevation of collagen Ⅰ and collagen Ⅲ protein expression in cardiac tissues of ISO-induced HF rats. Furthermore

HXP treatment significantly down-regulated the increase of TGF-β1 and p-Smad2/3 protein expression in cardiac tissues of HF rats (

0.05)

while did not affect the expression of total Smad2/3.

Conclusions:

HXP attenuated heart failure and cardiac fibrosis in ISO-induced HF rats by suppression of TGF-β1/Smad2/3 pathway.

关键词

Keywords

Huoxin Pillheart failurecardiac fibrosisisoproterenolTGF-β1/Smad2/3 pathway

references

BR Pagliaro, F Cannata, GG Stefanini, L Bolognese.Myocardial ischemia and coronary disease in heart failure.Heart Fail Rev 2020;25:53-65.

RV Shah, J Rong, MG Larson, A Yeri, O Ziegler, K Tanriverdi, et al. Associations of circulating extracellular RNAs with myocardial remodeling and heart failure. JAMA Cardiol 2018;3:871-876.

D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association.Circulation 2015;131:e329-e322.

D Levy, S Kenchaiah, MG Larson, EJ Benjamin, MJ Kupka, KK Ho, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402.

JL Januzzi, J Butler, E Fombu, A Maisel, K McCague, IL Piña, et al. Rationale and methods of the prospective study of biomarkers, symptom improvement, and ventricular remodeling during sacubitril/valsartan therapy for heart failure (PROVE-HF). Am Heart J 2018;199:130-136.

L Bacmeister, M Schwarzl, S Warnke, B Stoffers, S Blankenberg, D Westermann, et al. Inflammation and fibrosis in murine models of heart failure. Basic Res Cardiol 2019;114:19.

M Dobaczewski, M Bujak, N Li, C Gonzalez-Quesada, LH Mendoza, XF Wang, et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res 2010 6;107:418-428.

M Bujak, NG Frangogiannis. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-195.

A Tandon, JC Tovey, A Sharma, R Gupta, RR Mohan.Role of transforming growth factor beta in corneal function, biology and pathology. Curr Mol Med 2010;10:565-578.

J Hao, H Ju, S Zhao, A Junaid, T Scammell-La Fleur, IM Dixon. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 1999;31:667-678.

M Ikeuchi, H Tsutsui, T Shiomi, H Matsusaka, S Matsushima, J Wen, et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 2004;64:526-535.

Z Zeng, Q Wang, X Yang, Y Ren, S Jiao, Q Zhu, et al.Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway. Phytomedicine 2019;62:152949.

A Han, Y Lu, Q Zheng, J Zhang, Y Zhao, M Zhao, et al.Qiliqiangxin attenuates cardiac remodeling via inhibition of TGF-β1/Smad3 and NF-κB signaling pathways in a rat model of myocardial infarction. Cell Physiol Biochem 2018;45:1797-1806.

QW Wang, XF Yu, HL Xu, XZ Zhao, DY Sui. Ginsenoside Re improves isoproterenol-induced myocardial fibrosis and heart failure in rats. Evid Based Complement Alternat Med 2019;2019:3714508.

P Gong, Y Li, C Yao, H Guo, H Hwang, X Liu, et al.Traditional Chinese medicine on the treatment of coronary heart disease in recent 20 years. J Altern Complement Med 2017;23:659-666.

P Akila, L Asaikumar, L Vennila. Chlorogenic acid ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes.Biomed Pharmacother 2017;85:582-591.

S Rani, PK Sreenivasaiah, JO Kim, MY Lee, WS Kang, YS Kim, et al. Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress. PLoS One 2017;12:e0176071.

P Li, Q Song, T Liu, Z Wu, X Chu, X Zhang, et al. Inhibitory effect of cinobufagin on L-type Ca2+ currents, contractility, and Ca2+ homeostasis of isolated adult rat ventricular myocytes. Sci World J 2014;2014:496705.

X Wu, M Li, SQ Chen, S Li, F Guo. Pin1 facilitates isoproterenol-induced cardiac fibrosis and collagen deposition by promoting oxidative stress and activating the MEK1/2-ERK1/2 signal transduction pathway in rats. Int J Mol Med 2018;41:1573-1583.

AR Marks. Calcium cycling proteins and heart failure:mechanisms and therapeutics. J Clin Invest 2013;123:46-52.

LH Lu, C Li, QY Wang, Q Zhang, Y Zhang, H Meng, et al.Cardioprotective effects of Qishen Granule on sarcoplasmic reticulum Ca2+ handling in heart failure rats. Chin J Integr Med 2017;23:510-517.

YC Wang, DF Ma, P Jiang, YM Zhang, GF Zhou, JL Yang, et al. Guizhi Decoction inhibits cholinergic transdifferentiation by regulating imbalance of NGF and LIF in salt-sensitive hypertensive heart failure rats. Chin J Integr Med 2020;26:188-196.

H Yang, FF Zhang, XH Peng, DH Zhao, J Peng. Efficacy of medication directed by home-monitoring cardiac resynchronization therapy in chronic heart failure patients.Chin Med Sci J 2014;29:61-62.

L Li, J Hao, X Jiang, P Li, H Sen. Cardioprotective effects of ulinastatin against isoproterenol-induced chronic heart failure through the PI3K-Akt, p38 MAPK and NF-κB pathways. Mol Med Rep 2018;17:1354-1360.

JJ Wang, C Rau, R Avetisyan, S Ren, MC Romay, G Stolin, et al. Genetic dissection of cardiac remodeling in an isoproterenol-induced heart failure mouse model. PLoS Genet 2016;12:e1006038.

SS Mohamed, LA Ahmed, WA Attia, MM Khattab.Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats.Biochem Pharmacol 2015;98:403-411.

FD Siman, EA Silveira, AA Fernandes, I Stefanon, DV Vassallo, AS Padilha. Ouabain induces nitric oxide release by a PI3K/Akt-dependent pathway in isolated aortic rings from rats with heart failure. J Cardiovasc Pharmacol 2015;65:28-38.

JE Sanderson. New treatments for myocardial fibrosis.Cardiovasc Drugs Ther 2002;16:181-182.

DJ Lok, SI Lok, PW Bruggink-André de la Porte, E Badings, E Lipsic, J van Wijngaarden, et al. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol 2013;102:103-110.

A Biernacka, M Dobaczewski, NG Frangogiannis. TGF-β signaling in fibrosis. Growth Factors 2011;29:196-202.

PJ Lijnen, VV Petrov, RH Fagard. Induction of cardiac fibrosis by transforming growth factor-beta 1. Mol Genet Metab 2000;71:418-435.

P ten Dijke, HM Arthur. Extracellular control of TGF beta signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007;8:857-869.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effects of Buyang Huanwu Decoction on Intestinal Barrier, Intestinal Flora, and Trimethylamine Oxide in Rats with Heart Failure

Metabonomics: A Useful Tool to Reveal Underlying Relationships between Altered Chinese Medicine Syndromes and Ultrafiltration in Treatment of Heart Failure

Role of Chinese Herbal Medicines in Regulation of Energy Metabolism in Treating Cardiovascular Diseases

Related Author

No data

Related Institution

Department of Cardiology, Dongzhimen Hospital of Beijing University of Chinese Medicine

Department of Nuclear Medicine, Dongzhimen Hospital of Beijing University of Chinese Medicine

Peking University Sixth Hospital

Graduate School of Beijing University of Chinese Medicine

Cardiovascular Disease Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰